In this Issue:
Glucose and dementia risk
Glucose-lowering mechanisms of canagliflozin
Metabolic effects of bariatric surgery
Antiplatelet effects of ticagrelor vs. prasugrel
HbA1c variability correlates with nephropathy, not retinopathy
Glucose variability predicts hypoglycaemia during
pump therapy
HDL cholesterol and future type 2 diabetes development
Long-term QOL effects of type 1 diabetes treatment
Intensive SMBG in noninsulin-treated type 2 diabetes
Cognitive impairment risk with metformin
Please login below to download this issue (PDF)